Cynosure Group LLC Purchases New Position in Crocs, Inc. (NASDAQ:CROX)

Cynosure Group LLC purchased a new stake in Crocs, Inc. (NASDAQ:CROX) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 2,539 shares of the textile maker’s stock, valued at approximately $368,000.

Several other hedge funds have also recently bought and sold shares of CROX. Davis Investment Partners LLC increased its stake in shares of Crocs by 0.8% during the third quarter. Davis Investment Partners LLC now owns 9,673 shares of the textile maker’s stock worth $1,362,000 after purchasing an additional 77 shares during the period. Nisa Investment Advisors LLC increased its position in Crocs by 8.9% during the 2nd quarter. Nisa Investment Advisors LLC now owns 1,041 shares of the textile maker’s stock worth $152,000 after buying an additional 85 shares during the period. Central Pacific Bank Trust Division lifted its holdings in shares of Crocs by 8.0% during the third quarter. Central Pacific Bank Trust Division now owns 1,350 shares of the textile maker’s stock worth $195,000 after buying an additional 100 shares in the last quarter. 180 Wealth Advisors LLC boosted its position in shares of Crocs by 1.6% in the second quarter. 180 Wealth Advisors LLC now owns 7,248 shares of the textile maker’s stock valued at $1,036,000 after acquiring an additional 111 shares during the period. Finally, Covestor Ltd boosted its position in shares of Crocs by 10.3% in the third quarter. Covestor Ltd now owns 1,225 shares of the textile maker’s stock valued at $178,000 after acquiring an additional 114 shares during the period. 93.44% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, CFO Susan L. Healy acquired 1,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 13th. The stock was acquired at an average cost of $99.70 per share, for a total transaction of $99,700.00. Following the completion of the acquisition, the chief financial officer now directly owns 22,652 shares of the company’s stock, valued at approximately $2,258,404.40. This trade represents a 4.62 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director John B. Replogle bought 2,240 shares of the business’s stock in a transaction on Wednesday, October 30th. The shares were bought at an average cost of $112.60 per share, for a total transaction of $252,224.00. Following the completion of the acquisition, the director now directly owns 9,304 shares in the company, valued at approximately $1,047,630.40. This trade represents a 31.71 % increase in their position. The disclosure for this purchase can be found here. Insiders own 2.72% of the company’s stock.

Crocs Price Performance

CROX stock opened at $105.60 on Friday. Crocs, Inc. has a 1 year low of $85.71 and a 1 year high of $165.32. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.43 and a quick ratio of 0.90. The stock has a market cap of $6.15 billion, a price-to-earnings ratio of 7.66, a P/E/G ratio of 1.10 and a beta of 2.01. The company has a 50 day simple moving average of $123.20 and a 200 day simple moving average of $135.04.

Crocs (NASDAQ:CROX) last announced its quarterly earnings results on Tuesday, October 29th. The textile maker reported $3.60 EPS for the quarter, beating analysts’ consensus estimates of $3.10 by $0.50. The company had revenue of $1.06 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Crocs had a return on equity of 49.70% and a net margin of 20.50%. Crocs’s revenue was up 1.6% compared to the same quarter last year. During the same period in the prior year, the company earned $3.25 EPS. Research analysts anticipate that Crocs, Inc. will post 12.93 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. Monness Crespi & Hardt dropped their price objective on shares of Crocs from $170.00 to $140.00 and set a “buy” rating for the company in a research note on Wednesday, October 30th. UBS Group lowered their target price on shares of Crocs from $146.00 to $122.00 and set a “neutral” rating on the stock in a report on Wednesday, October 30th. Robert W. Baird cut their price target on Crocs from $190.00 to $180.00 and set an “outperform” rating for the company in a research note on Wednesday, October 30th. Guggenheim lowered their price objective on Crocs from $182.00 to $155.00 and set a “buy” rating on the stock in a research note on Wednesday, October 30th. Finally, KeyCorp cut their target price on Crocs from $155.00 to $150.00 and set an “overweight” rating for the company in a research report on Wednesday, October 30th. Five investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $148.80.

Crocs Company Profile

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.